ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
256.55
+5.04 (2.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
ResMed Employees
ResMed had 9,980 employees as of June 30, 2024. The number of employees decreased by 160 or -1.58% compared to the previous year.
Employees
9,980
Change (1Y)
-160
Growth (1Y)
-1.58%
Revenue / Employee
$526,794
Profits / Employee
$144,079
Market Cap
37.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | 7,770 | 530 | 7.32% |
| Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
| Jun 30, 2018 | 5,940 | -140 | -2.30% |
| Jun 30, 2017 | 6,080 | 830 | 15.81% |
| Jun 30, 2016 | 5,250 | 910 | 20.97% |
| Jun 30, 2015 | 4,340 | 240 | 5.85% |
| Jun 30, 2014 | 4,100 | 200 | 5.13% |
| Jun 30, 2013 | 3,900 | 200 | 5.41% |
| Jun 30, 2012 | 3,700 | 250 | 7.25% |
| Jun 30, 2011 | 3,450 | 250 | 7.81% |
| Jun 30, 2010 | 3,200 | 300 | 10.34% |
| Jun 30, 2009 | 2,900 | 200 | 7.41% |
| Jun 30, 2008 | 2,700 | 0 | - |
| Jun 30, 2007 | 2,700 | 200 | 8.00% |
| Jun 30, 2006 | 2,500 | 573 | 29.74% |
| Jun 30, 2005 | 1,927 | 407 | 26.78% |
| Jun 30, 2004 | 1,520 | 56 | 3.83% |
| Jun 30, 2003 | 1,464 | 214 | 17.12% |
| Jun 30, 2002 | 1,250 | 297 | 31.16% |
| Jun 30, 2001 | 953 | 348 | 57.52% |
| Jun 30, 2000 | 605 | 104 | 20.76% |
| Jun 30, 1999 | 501 | 111 | 28.46% |
| Jun 30, 1998 | 390 | 106 | 37.32% |
| Jun 30, 1997 | 284 | 55 | 24.02% |
| Jun 30, 1996 | 229 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RMD News
- 12 days ago - IDEXX Laboratories Vs ResMed: Which Stock Could Rally? - Forbes
- 18 days ago - ResMed: Safe Bet For A Recession Environment - Seeking Alpha
- 24 days ago - Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete? - The Motley Fool
- 5 weeks ago - These Analysts Revise Their Forecasts On ResMed Following Q1 Results - Benzinga
- 5 weeks ago - ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026 - GlobeNewsWire
- 2 months ago - Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025 - GlobeNewsWire
- 2 months ago - Top 50 High-Quality Dividend Growth Stocks For October 2025 - Seeking Alpha